← Back to Search

Behavioural Intervention

Culturally Tailored Anti-Smoking Messages for Cigarette Smoking

N/A
Waitlist Available
Research Sponsored by Abramson Cancer Center of the University of Pennsylvania
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up days 0, 30
Awards & highlights

Study Summary

This trial is testing whether culturally tailored messages can help young adult sexual minority women resist tobacco marketing.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~days 0, 30
This trial's timeline: 3 weeks for screening, Varies for treatment, and days 0, 30 for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in intention to purchase cigarettes
Change in intention to quit smoking

Trial Design

9Treatment groups
Experimental Treatment
Active Control
Group I: Three Messages ImmediateExperimental Treatment1 Intervention
Participants will receive three anti-smoking messages, followed by the threat message during the baseline survey. Outcomes will be measured before seeing the anti-smoking messages and threat message, immediately after seeing the threat message, and at 1 month.
Group II: Three Messages 1 Week DelayExperimental Treatment1 Intervention
Participants will receive three anti-smoking messages during the baseline survey, followed by the threat message one week later in a separate survey. Outcomes will be measured before seeing the anti-smoking messages at baseline, immediately after seeing the threat message at 1 week, and at 1 month.
Group III: Three Messages 1 Month Delay Repeat ExposureExperimental Treatment1 Intervention
Participants will receive three anti-smoking messages during the baseline survey, followed by the threat message one month later. Participants will also receive repeated exposures of three anti-smoking messages at 1, 2, and 3 weeks in separate surveys. Outcomes will be measured before seeing the anti-smoking messages at baseline and immediately after seeing the threat message at 1 month.
Group IV: Three Messages 1 Month DelayExperimental Treatment1 Intervention
Participants will receive three anti-smoking messages during the baseline survey, followed by the threat message one month later in a separate survey. Outcomes will be measured before seeing the anti-smoking messages at baseline, and immediately after seeing the threat message at 1 month.
Group V: Single Message ImmediateExperimental Treatment1 Intervention
Participants will receive a single anti-smoking message followed by the threat message during the baseline survey. Outcomes will be measured before seeing the anti-smoking message and threat message, immediately after seeing the threat message, and at 1 month.
Group VI: Single Message 1 Week DelayExperimental Treatment1 Intervention
Participants will receive a single anti-smoking message during the baseline survey, followed by the threat message one week later in a separate survey. Outcomes will be measured before seeing the anti-smoking message at baseline, immediately after seeing the threat message at 1 week, and at 1 month.
Group VII: Single Message 1 Month Delay, Repeated ExposureExperimental Treatment1 Intervention
Participants will receive a single anti-smoking message during the baseline survey, followed by the threat message one month later. Participants will also receive repeated exposures of a single anti-smoking message at 1, 2, and 3 weeks in separate surveys. Outcomes will be measured before seeing the anti-smoking message at baseline and immediately after seeing the threat message at 1 month.
Group VIII: Single Message 1 Month DelayExperimental Treatment1 Intervention
Participants will receive a single anti-smoking message during the baseline survey, followed by the threat message one month later in a separate survey. Outcomes will be measured before seeing the anti-smoking message at baseline, and immediately after seeing the threat message at 1 month.
Group IX: No Message ConditionActive Control1 Intervention
Participants will receive no anti-smoking messages. They will receive the threat message during the baseline survey. Outcomes will be measured before and immediately after seeing the threat message, and at 1 month.

Find a Location

Who is running the clinical trial?

Abramson Cancer Center of the University of PennsylvaniaLead Sponsor
359 Previous Clinical Trials
102,504 Total Patients Enrolled
Abramson Cancer Center at Penn MedicineLead Sponsor
387 Previous Clinical Trials
143,104 Total Patients Enrolled
National Cancer Institute (NCI)NIH
13,654 Previous Clinical Trials
40,930,562 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Does the current trial accept applicants beyond the age of 70?

"As indicated in the study's criteria, the lower age boundary for participation is 18 and no more than 30 years old can join."

Answered by AI

What is the scope of participants for this trial?

"Affirmative. Clinicaltrials.gov displays that this medical experiment, initially made public on September 21st 2022, is currently welcoming participants. The researchers are looking to recruit 3000 patients at a singular location."

Answered by AI

Are any additional participants being actively sought for this trial?

"Correct. Clinicaltrials.gov records show that this medical trial, which launched on September 21st 2022, is currently recruiting participants. 3000 individuals need to be enrolled from one site in particular."

Answered by AI

To what demographic is the enrollment for this experimentation open?

"The trial is in need of 3000 individuals, between the ages 18 and 30 with a history of tobacco use. In addition to this criteria, these participants must also be female, identify as non-heterosexual, live within America's borders and have English fluency."

Answered by AI

Who else is applying?

What state do they live in?
Pennsylvania
How old are they?
18 - 65
What site did they apply to?
University of Pennsylvania
What portion of applicants met pre-screening criteria?
Met criteria
Recent research and studies
clinicaltrials.govStudy
Project RESIST: Evaluating the Effects of Anti-smoking Inoculation Messages Among Young Adult Sexual Minority Women
Andy Tan 2022. "Project RESIST: Evaluating the Effects of Anti-smoking Inoculation Messages Among Young Adult Sexual Minority Women". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05499520.
~1036 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top